Volume 53, Issue 1, Pages (January 2008)

Slides:



Advertisements
Similar presentations
Volume 53, Issue 3, Pages (March 2008)
Advertisements

Volume 165, Issue 5, Pages (May 2001)
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 2, Pages (August 2010)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 50, Issue 5, Pages (November 2006)
Testosterone Therapy in Men With Prostate Cancer
Volume 58, Issue 5, Pages (November 2010)
Volume 70, Issue 6, Pages (December 2016)
Volume 66, Issue 1, Pages (July 2014)
Volume 61, Issue 5, Pages (May 2012)
Volume 63, Issue 4, Pages (April 2013)
Volume 50, Issue 5, Pages (November 2006)
Volume 68, Issue 3, Pages (September 2015)
Volume 52, Issue 3, Pages (September 2007)
Volume 70, Issue 6, Pages (December 2016)
Volume 51, Issue 3, Pages (March 2007)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Volume 72, Issue 5, Pages (November 2017)
Volume 52, Issue 4, Pages (October 2007)
Volume 61, Issue 4, Pages (April 2012)
Volume 63, Issue 1, Pages (January 2013)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Nomograms for Bladder Cancer
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 51, Issue 1, Pages (January 2007)
Volume 51, Issue 5, Pages (May 2007)
Volume 73, Issue 2, Pages (February 2018)
Volume 61, Issue 5, Pages (May 2012)
Volume 61, Issue 4, Pages (April 2012)
Volume 60, Issue 5, Pages (November 2011)
Volume 67, Issue 3, Pages (March 2015)
Volume 64, Issue 5, Pages (November 2013)
Volume 68, Issue 1, Pages (July 2015)
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
Volume 52, Issue 3, Pages (September 2007)
Volume 64, Issue 3, Pages (September 2013)
Volume 71, Issue 6, Pages (June 2017)
Volume 64, Issue 4, Pages (October 2013)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 2, Pages (August 2014)
Volume 63, Issue 3, Pages (March 2013)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 71, Issue 1, Pages (January 2017)
The Economic Costs of Overactive Bladder in Germany
Volume 62, Issue 3, Pages (September 2012)
Volume 50, Issue 5, Pages (November 2006)
Volume 52, Issue 6, Pages (December 2007)
Volume 71, Issue 5, Pages (May 2017)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
European Urology is “Your” Journal
A.H. Gifford  Journal of Cystic Fibrosis 
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 55, Issue 6, Pages (June 2009)
Volume 54, Issue 1, Pages (July 2008)
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
Volume 52, Issue 4, Pages (October 2007)
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Volume 51, Issue 2, Pages (February 2007)
Volume 52, Issue 1, Pages (July 2007)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Maximilian Burger, Ashish M. Kamat, David McConkey 
Presentation transcript:

Volume 53, Issue 1, Pages 146-152 (January 2008) Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?  Stefan Denzinger, Hans-Martin Fritsche, Wolfgang Otto, Andreas Blana, Wolf-Ferdinand Wieland, Maximilian Burger  European Urology  Volume 53, Issue 1, Pages 146-152 (January 2008) DOI: 10.1016/j.eururo.2007.06.030 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier analysis of cancer-specific survival in patients with early (orange line) versus deferred (blue line) cystectomy. European Urology 2008 53, 146-152DOI: (10.1016/j.eururo.2007.06.030) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 (A) Kaplan-Meier analysis of cancer-specific survival in patients undergoing early cystectomy with concomitant carcinoma in situ (CIS) (orange line) and without concomitant CIS (blue line). (B) Kaplan-Meier analysis of cancer-specific survival in patients undergoing deferred cystectomy with concomitant CIS (orange line) and without concomitant CIS (blue line). European Urology 2008 53, 146-152DOI: (10.1016/j.eururo.2007.06.030) Copyright © 2007 European Association of Urology Terms and Conditions